Filing Details

Accession Number:
0001689923-22-000025
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-02-18 19:52:52
Reporting Period:
2022-02-18
Accepted Time:
2022-02-18 19:52:52
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1689923 Alteryx Inc. AYX Services-Specialty Outpatient Facilities, Nec (8093) MN
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1115047 I Timothy Maudlin C/O Alteryx, Inc.
17200 Laguna Canyon Road
Irvine CA 92618
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Class A Common Stock Acquisiton 2022-02-18 43,000 $0.00 46,772 No 4 C Direct
Class A Common Stock Disposition 2022-02-18 8,918 $55.73 37,854 No 4 S Direct
Class A Common Stock Disposition 2022-02-18 315 $56.42 37,539 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 C Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Class B Common Stock Stock Option (Right to Buy) Disposition 2022-02-18 43,000 $0.00 43,000 $11.88
Class A Common Stock Class B Common Stock Acquisiton 2022-02-18 43,000 $0.00 43,000 $0.00
Class A Common Stock Class B Common Stock Disposition 2022-02-18 43,000 $0.00 43,000 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
36,451 2018-01-05 2025-12-19 No 4 M Direct
43,000 No 4 M Direct
0 No 4 C Direct
Footnotes
  1. Each share of Class B Common Stock is convertible, at any time at the option of the holder, into one (1) share of Class A Common Stock. In addition, each share of Class B Common Stock will convert automatically into one (1) share of Class A Common Stock upon the transfer, whether or not for value, to any transferee who is not a "Permitted Transferee", as defined in the Issuer's Restated Certificate of Incorporation in effect as of the date hereof. The shares of Class B Common Stock have no expiration date.
  2. Includes 2,397 unvested shares subject to awards of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Class A Common Stock upon settlement for no consideration. Shares of the Issuer's Class A Common Stock will be delivered to the Reporting Person following vesting.
  3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.37 to $56.25, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.
  4. Each share of Class B Common Stock will convert automatically into one (1) share of Class A Common Stock upon the earliest to occur of the following: (a) the date specified by a vote of the holders of 66 2/3% of the outstanding shares of Class B Common Stock, (b) March 23, 2027, and (c) the date the shares of Class B Common Stock cease to represent at least 10% of all outstanding shares of Common Stock. The shares of Class A Common Stock and Class B Common Stock have no expiration date.